ViiV registers two HIV studies: DDI trial for VH4011499 and NIAID-led PALACE trialNov 16Weekly roundup, 2 itemscabotegravirGilead Sciences
FDA approves Sunharbo, first factor XIa inhibitor, for secondary stroke preventionNov 9Regulatory decisionBayer
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
FDA clears three labeling supplements for palonosetron, letrozole, carbamazepineSep 17Weekly roundup, 3 itemscarbamazepineletrozole
Lilly posts results for five completed Phase 1 studies, opens three new early trialsJul 17Weekly roundup, 8 itemsEli Lillyeloralintide
Novartis posts pelacarsen Phase 3 apheresis results, updates three drug labelsJul 17Weekly roundup, 8 itemscarbamazepineimatinib